Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys
International Journal of Molecular Sciences · 28.06.2025 · 26 (13) · 6247
DOI: 10.3390/ijms26136247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.06.2025. Verfasst von Justyna Zbrzeźniak-Suszczewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland. Hauptthemen laut MEDLINE: Obesity, Adiposity, Kidney. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Warmia and Mazury in Olsztyn.
Abstract (Originalsprache)
Obesity, hypertension, and chronic kidney disease (CKD) constitute the deadly trinity of modern threats for populations of both developed and developing countries. These diseases (together with type 2 diabetes) are closely linked in their pathophysiology and result in increasing cardiovascular (CV) morbidity and premature death from CV causes. In this review, we focused on the kidney as the target of obesity-related disorders. Obesity-related glomerulosclerosis (ORG) represents a pattern of renal injury caused solely or predominantly by obesity; usually, it is superimposed on chronic kidney disease (CKD) from other causes, such as diabetic kidney disease, hypertensive kidney disease, type 2 cardiorenal syndrome, primary or secondary glomerulopathies, and others. Adipose tissue contributes to kidney injury in several ways: it releases proinflammatory cytokines and growth factors, leading to podocyte and mesangial cell injury and glomerulosclerosis. In particular, perirenal adipose tissue (PRAT), besides exerting paracrine and endocrine effects on the kidney, modifies its function via compression on renal parenchyma and vessels. The intrinsic ability of the kidneys in obesity to increase the reabsorption of sodium warrants intraglomerular hypertension and hyperfiltration, followed by progressive renal injury. Lifestyle interventions and pharmacological agents, as well as metabolic (bariatric) surgery resulting in weight reduction, may also be beneficial for the kidneys. Using GLP1 receptor agonists (with a special focus on subcutaneous semaglutide and tirzepatide) seems to be the most promising treatment strategy for preventing kidney injury in obese individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
- Department of Pathology, Medical University of Warsaw, 02-091 Warsaw, Poland.
ORCID-Profile: Justyna Zbrzeźniak-Suszczewicz, Agata Winiarska
Förderung
- University of Warmia and Mazury in Olsztyn
Zitieren
APA
Zbrzeźniak-Suszczewicz, J., Winiarska, A., Perkowska-Ptasińska, A., & Stompór, T. (2025). Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys. International Journal of Molecular Sciences, 26(13), 6247. https://doi.org/10.3390/ijms26136247
Vancouver
Zbrzeźniak-Suszczewicz J, Winiarska A, Perkowska-Ptasińska A, Stompór T. Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys. International Journal of Molecular Sciences. 2025;26(13):6247. doi:10.3390/ijms26136247
BibTeX
@article{ZbrzeniakSuszczewicz2025,
author = {Zbrzeźniak-Suszczewicz, Justyna and Winiarska, Agata and Perkowska-Ptasińska, Agnieszka and Stompór, Tomasz},
title = {Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6247},
doi = {10.3390/ijms26136247}
}
EUVIMED